Clinical
RSSArticles
-
Physician Burnout: A Multi-specialty Perspective
Although different specialties address the problem of physician burnout, studies suggest the most effect is gained from organizational interventions.
-
Another Reason to Get the Flu Shot Every Year
In a case-control study, among older adults, repeated vaccination for influenza was twice as effective in preventing severe influenza compared to non-severe influenza in patients who were admitted to the hospital.
-
The Latest in Genetic Screening for Gynecologic Malignancies
Genetic testing is changing rapidly. With the advent of more sophisticated genetic mutation panels, it is important that providers of women’s healthcare consider appropriate referral and testing for those women at increased risk of malignancy.
-
Breast MRI Exams Increase the Biopsy Rate Without Improving Cancer Detection
Compared to women who undergo breast cancer screening with mammography alone, those receiving MRI exams experience a two- to fivefold increased rate of core and surgical biopsy. However, the biopsies have a lower cancer yield rate than mammography alone.
-
Obesity and Prolapse: Are They Related?
Women with a body mass index in the overweight and obese range are more likely to experience pelvic organ prolapse compared to women in the normal range.
-
Induction of Labor at 39 Weeks
Inducing low-risk obstetrical patients at 39 weeks may be associated with lower rates of cesarean delivery and the need for neonatal respiratory support.
-
FDA Actions
In this section: The agency approves a new drug for prostate cancer and expands the indication for a non-small cell lung cancer treatment.
-
Influenza A Renders This Year’s Flu Vaccine Ineffective
This year’s flu vaccine was only 36% effective, according to the CDC.
-
What About Aspirin for PCI Patients?
Should clinicians continue using aspirin for patients with prior percutaneous coronary intervention who are undergoing noncardiac surgery? The answer appears to be yes based on the results of a new study from Canada.
-
Comparing Treatments for Cancer-associated VTE
Researchers have determined that edoxaban was noninferior to dalteparin regarding the composite outcome of recurrent VTE or major bleeding, although recurrent VTE was lower and bleeding was higher with edoxaban.